Tectonic Therapeutic, Inc.(TECX)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Ruddy Marcella K. Chief Medical Officer | Sale | -1,065 | -1.55%67,682 | $30.00 | $31,950 | View SEC filing | |
| 2026-04-03 | Ruddy Marcella K. Chief Medical Officer | Sale | -1,000 | -1.43%68,747 | $31.05 | $31,050 | View SEC filing | |
| 2026-03-09 | Ruddy Marcella K. Chief Medical Officer | Sale | -10,000 | -12.54%69,747 | $30.00 | $300,000 | View SEC filing | |
| 2026-03-09 | McNamara Peter Chief Scientific Officer | Sale | -6,262 | -10.17%55,285 | $30.17 | $188,935 | View SEC filing | |
| 2026-03-05 | McNamara Peter Chief Scientific Officer | Sale | -3,299 | +50.35%58,832 | $23.53 | $77,627 | View SEC filing | |
| 2026-03-05 | REICIN ALISE Chief Executive Officer | Purchase | +2,500 | +2.01%127,030 | $21.10 | $52,750 | View SEC filing | |
| 2026-02-12 | REICIN ALISE Chief Executive Officer | Purchase | +2,500 | +1.06%237,547 | $21.10 | $52,750 | View SEC filing | |
| 2026-02-11 | Lochner Daniel Chief Financial Officer | Purchase | +6,000 | +23.04%32,044 | $21.61 | $129,660 | View SEC filing | |
| 2025-04-11 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +141,923 | +2.49%5,838,204 | $16.20 | $2,299,015 | View SEC filing | |
| 2025-04-09 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +500,000 | +9.62%5,696,281 | $17.10 | $8,550,000 | View SEC filing | |
| 2025-04-07 | MCGUIRE TERRANCE Director | Sale | -500,000 | -46.60%573,062 | $17.10 | $8,550,000 | View SEC filing | |
| 2025-02-07 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +789,294 | +17.91%5,196,281 | $50.68 | $39,999,977 | View SEC filing | |
| 2025-02-07 | Lochner Daniel Chief Financial Officer | Purchase | +4,617 | +100.00%4,617 | $54.14 | $249,964 | View SEC filing | |
| 2024-10-24 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +300,000 | +7.90%4,096,764 | $33.59 | $10,077,000 | View SEC filing | |
| 2024-09-26 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +50,000 | +1.33%3,796,764 | $28.82 | $1,440,829 | View SEC filing | |
| 2024-05-15 | Leonard Braden Michael 10% Owner | Purchase | +766,635 | +19.16%4,768,262 | $1.27 | $971,493 | View SEC filing | |
| 2021-07-08 | Vickers Philip J. Director | Purchase | +4,800 | +100.00%4,800 | $8.35 | $40,080 | View SEC filing | |
| 2021-02-18 | Donenberg Phillip B. Director | Purchase | +2,000 | +100.00%2,000 | $11.71 | $23,420 | View SEC filing | |
| 2020-02-14 | MACKAY GEOFFREY See Remarks | Sale | -1,400 | -0.40%345,123 | $29.07 | $40,692 | View SEC filing | |
| 2020-02-11 | PAIGE CHRISTOPHER Director | Sale | -15,000 | -5.61%252,512 | $28.00 | $420,000 | View SEC filing | |
| 2020-02-11 | MACKAY GEOFFREY See Remarks | Sale | -63,000 | -15.38%346,523 | $27.57 | $1,737,081 | View SEC filing | |
| 2020-01-30 | PAIGE CHRISTOPHER Director | Sale | -10,000 | -3.60%267,512 | $23.00 | $230,000 | View SEC filing | |
| 2019-07-23 | Atlas Venture Fund X, L.P. 10% Owner | Purchase | +810,811 | +17.05%5,567,289 | $18.50 | $15,000,004 | View SEC filing | |
| 2019-07-23 | Booth Bruce Director | Purchase | +810,811 | +17.05%5,567,289 | $18.50 | $15,000,004 | View SEC filing | |
| 2019-04-09 | PAIGE CHRISTOPHER Director | Sale | -10,000 | -3.48%277,512 | $25.72 | $257,196 | View SEC filing |
1-25 of 26